Radionetics Oncology
Discovering and developing novel radiotherapeutics for the treatment of cancer.
48 employees · est. 2021 · San Diego, United States
Rexahn Pharmaceuticals
TARGETING DIFFICULT TO TREAT CANCERS
7 employees · est. 2001 · Rockville, United States
Rexahn Pharmaceuticals is the older company (2021 vs 2001); Radionetics Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | Radionetics Oncology | Rexahn Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2001 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Rockville, United States |
| Employees | ||
| Employees | 48 larger | 7 |
| Industry | ||
| Industry | Health Care, Health and Wellness, Pharmaceutical | Biotechnology, Medical Devices, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $135.00M | $13.60M |
| Funding Rounds | ||
| Funding Rounds | 3 | 2 |
| Services | ||
| Services | Development of precision radiopharmaceuticals, Targeted cancer therapy solutions, Theranostic applications for diagnostics and treatment, Small molecule radioligand pipeline for cancer | Not tracked yet |
| Target Customers | ||
| Target Customers | Oncology patients, Healthcare providers specializing in cancer treatment, Pharmaceutical companies interested in novel cancer therapies, Medical research institutions focusing on oncology | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Radiopharmaceuticals, Oncology, Radiotherapeutics, GPCR Targeting, Small Molecule Radioligands, Breast Cancer Treatment, Lung Cancer Treatment, Clinical Stage, Cancer Research, Pharmaceuticals, Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, Strategic Partnership | Rexahn Pharmaceuticals Inc., Biopharmaceutical, Cancer, Clinical Stage, Therapeutics, Targeted Therapy, Cancer Treatment, Oncology, Product Candidates, Phase 2 Clinical Development, Drug Resistance, Toxicity, Side Effects, FDA-approved, Preclinical Development |
| Website | ||
| Website | radionetics.com | rexahn.com |
About Radionetics Oncology
Radionetics Oncology is a clinical-stage radiopharmaceutical company, inaugurated in 2021, specializing in the discovery and development of novel radiotherapeutics aimed at treating varied oncology indications. The company is headquartered in the United States and is at the forefront of leveraging a...
About Rexahn Pharmaceuticals
Rexahn Pharmaceuticals is a NY Stock Exchange listed biopharmaceutical company focusing on the development of targeted therapeutics for cancer treatment. Established in 2001, Rexahn's mission is to enhance the lives of cancer patients by creating next-generation therapies with increased efficacy and...
We will tell you when either one moves
BounceWatch watches Radionetics Oncology and Rexahn Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Radionetics Oncology and Rexahn Pharmaceuticals — by email.
Frequently Asked Questions
Compare Radionetics Oncology with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Radionetics Oncology on 9 Jun 2026, and Rexahn Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
